Exploration of Biomedical Dendrimer Space Based on In-Vivo
REVIEWS Drug Discovery Today Volume 24, Number 5 May 2019 Exploration of biomedical dendrimer Reviews space based on in-vivo POST SCREEN physicochemical parameters: Key factor analysis (Part 2) 1,2,3,4 2,5 3 6 Serge Mignani , João Rodrigues , René Roy , Xiangyang Shi , 7,8 9 4,10,11 Valentin Ceña , Saïd El Kazzouli and Jean-Pierre Majoral 1 Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS UMR 860, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologique, 45, rue des Saints Peres, 75006 Paris, France 2 CQM – Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal 3 Glycovax Pharma, 424 Guy Street, Suite 202, Montreal, Quebec H3J 1S6, Canada 4 Department of Pharmacy, Zhengzhou Railway Vocational & Technical College, Zhengzhou 450018, China 5 School of Materials Science and Engineering/Center for Nano Energy Materials, Northwestern Polytechnical University, Xi’an 710072, China 6 State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, PR China 7 Unidad Asociada Neurodeath, Universidad de Castilla-La Mancha, 02006 Albacete, Spain 8 Centro de Investigación Biomédica en Red para Enfermedades Neurodegenerativas, ISCIII, 28031 Madrid, Spain 9 Euromed Research Center, Euromed Faculty of Engineering, Euromed University of Fes (UEMF), Route de Meknès, 30000 Fès, Morocco 10 Laboratoire de Chimie de Coordination du CNRS, 205 route de Narbonne, 31077 Toulouse Cedex 4, France 11 Université Toulouse 118 route de Narbonne, 31077 Toulouse Cedex 4, France In nanomedicine, the widespread concern of nanoparticles in general, and dendrimers, in particular, is the analysis of key in-vivo physicochemical parameters to ensure the preclinical and clinical development of ‘safe’ bioactive nanomaterials.
[Show full text]